• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B类G蛋白偶联受体对神经肽垂体腺苷酸环化酶激活肽(PACAP)和血管活性肠肽(VIP)选择性的分子基础

Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP.

作者信息

Liao Chenyi, Remington Jacob M, May Victor, Li Jianing

机构信息

Department of Chemistry, University of Vermont, Burlington, VT, United States.

State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Dalian, China.

出版信息

Front Mol Biosci. 2021 Mar 25;8:644644. doi: 10.3389/fmolb.2021.644644. eCollection 2021.

DOI:10.3389/fmolb.2021.644644
PMID:33842547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8027070/
Abstract

The related neuropeptides PACAP and VIP, and their shared PAC1, VPAC1 and VPAC2 receptors, regulate a large array of physiological activities in the central and peripheral nervous systems. However, the lack of comparative and molecular mechanistic investigations hinder further understanding of their preferred binding selectivity and function. PACAP and VIP have comparable affinity at the VPAC1 and VPAC2 receptor, but PACAP is 400-1,000 fold more potent than VIP at the PAC1 receptor. A molecular understanding of the differing neuropeptide-receptor interactions and the details underlying the receptor transitions leading to receptor activation are much needed for the rational design of selective ligands. To these ends, we have combined structural information and advanced simulation techniques to study PACAP/VIP binding selectivity, full-length receptor conformation ensembles and transitions of the PACAP/VIP receptor variants and subtypes, and a few key interactions in the orthosteric-binding pocket. Our results reveal differential peptide-receptor interactions (at the atomistic detail) important for PAC1, VPAC1 and VPAC2 receptor ligand selectivity. Using microsecond-long molecular dynamics simulations and the Markov State Models, we have also identified diverse receptor conformational ensembles and microstate transition paths for each receptor, the potential mechanisms underlying receptor open and closed states, and the interactions and dynamics at the transmembrane orthosteric pocket for receptor activation. These analyses reveal important features in class B GPCR structure-dynamics-function relationships, which provide novel insights for structure-based drug discovery.

摘要

相关神经肽垂体腺苷酸环化酶激活肽(PACAP)和血管活性肠肽(VIP)及其共同的PAC1、VPAC1和VPAC2受体,调节中枢和外周神经系统中的一系列生理活动。然而,缺乏比较性和分子机制研究阻碍了对它们偏好的结合选择性和功能的进一步理解。PACAP和VIP在VPAC1和VPAC2受体上具有相当的亲和力,但PACAP在PAC1受体上的效力比VIP高400 - 1000倍。为了合理设计选择性配体,非常需要从分子层面了解不同的神经肽 - 受体相互作用以及导致受体激活的受体转变背后的细节。为此,我们结合了结构信息和先进的模拟技术,来研究PACAP/VIP的结合选择性、PACAP/VIP受体变体和亚型的全长受体构象集合及转变,以及正构结合口袋中的一些关键相互作用。我们的结果揭示了对PAC1、VPAC1和VPAC2受体配体选择性很重要的不同肽 - 受体相互作用(在原子细节层面)。通过微秒级的分子动力学模拟和马尔可夫状态模型,我们还确定了每个受体不同的受体构象集合和微观状态转变路径、受体开放和关闭状态的潜在机制,以及跨膜正构口袋中受体激活的相互作用和动力学。这些分析揭示了B类G蛋白偶联受体结构 - 动力学 - 功能关系中的重要特征,为基于结构的药物发现提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/2b17ed327a37/fmolb-08-644644-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/a911e63aba4e/fmolb-08-644644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/130f60802158/fmolb-08-644644-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/a40bbe8f0cd0/fmolb-08-644644-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/2b17ed327a37/fmolb-08-644644-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/a911e63aba4e/fmolb-08-644644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/130f60802158/fmolb-08-644644-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/a40bbe8f0cd0/fmolb-08-644644-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440e/8027070/2b17ed327a37/fmolb-08-644644-g004.jpg

相似文献

1
Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP.B类G蛋白偶联受体对神经肽垂体腺苷酸环化酶激活肽(PACAP)和血管活性肠肽(VIP)选择性的分子基础
Front Mol Biosci. 2021 Mar 25;8:644644. doi: 10.3389/fmolb.2021.644644. eCollection 2021.
2
Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.垂体腺苷酸环化酶激活多肽及PACAP受体在大鼠肾上腺中的表达与功能
Int J Mol Med. 2002 Mar;9(3):233-43.
3
Signal Transduction by VIP and PACAP Receptors.血管活性肠肽和垂体腺苷酸环化酶激活肽受体介导的信号转导
Biomedicines. 2022 Feb 9;10(2):406. doi: 10.3390/biomedicines10020406.
4
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.克隆的蛙血管活性肠肽/垂体腺苷酸环化酶激活肽受体具有哺乳动物中VPAC1和VPAC2受体的药理学及组织分布特征。
Endocrinology. 1999 Mar;140(3):1285-93. doi: 10.1210/endo.140.3.6576.
5
Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.塑造中枢神经系统发育的神经肽:血管活性肠肽(VIP)和垂体腺苷酸环化酶激活肽(PACAP)通过互补信号通路的时空作用。
J Neurosci Res. 2016 Dec;94(12):1472-1487. doi: 10.1002/jnr.23915. Epub 2016 Sep 26.
6
PACAP and PAC1 receptor in brain development and behavior.脑发育和行为中的 PACAP 和 PAC1 受体。
Neuropeptides. 2013 Dec;47(6):421-30. doi: 10.1016/j.npep.2013.10.005. Epub 2013 Oct 23.
7
A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.使用构象受限类似物对垂体腺苷酸环化酶激活肽进行的结构-功能研究:PAC1受体选择性垂体腺苷酸环化酶激活肽激动剂的鉴定。
Peptides. 2015 Apr;66:26-42. doi: 10.1016/j.peptides.2015.01.009. Epub 2015 Feb 16.
8
Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.人肿瘤及其起源组织中的血管活性肠肽/垂体腺苷酸环化酶激活肽受体亚型
Cancer Res. 2000 Jun 1;60(11):3105-12.
9
PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.促肾上腺皮质激素释放激素-38(PACAP-38)而非血管活性肠肽(VIP)通过一种不同于PAC1受体的受体诱导三叉神经尾侧核释放降钙素基因相关肽(CGRP)。
Neuropeptides. 2014 Apr;48(2):53-64. doi: 10.1016/j.npep.2014.01.004. Epub 2014 Jan 25.
10
Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity.定义PAC1受体选择性的垂体腺苷酸环化酶激活多肽(PACAP)的结构基序。
Regul Pept. 1999 Feb 5;79(2-3):83-92. doi: 10.1016/s0167-0115(98)00147-5.

引用本文的文献

1
Probing PAC1 receptor activation across species with an engineered sensor.用工程化传感器在不同物种中探测 PAC1 受体的激活。
Elife. 2024 Aug 15;13:RP96496. doi: 10.7554/eLife.96496.
2
Evaluation of Essential Dynamics and Fixed-Length Coarse Graining for Multidomain Proteins.多结构域蛋白质的主成分动力学与固定长度粗粒化评估
J Phys Chem B. 2024 May 30;128(21):5147-5156. doi: 10.1021/acs.jpcb.3c08198. Epub 2024 May 17.
3
Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization.

本文引用的文献

1
Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy.冷冻电镜结构解析揭示 VIP1 受体-G 蛋白复合物的激活状态 通过 NanoBiT 连接策略。
Nat Commun. 2020 Aug 17;11(1):4121. doi: 10.1038/s41467-020-17933-8.
2
Cryo-EM structure of the human PAC1 receptor coupled to an engineered heterotrimeric G protein.冷冻电镜结构解析人源 PAC1 受体与工程化异源三聚体 G 蛋白复合物
Nat Struct Mol Biol. 2020 Mar;27(3):274-280. doi: 10.1038/s41594-020-0386-8. Epub 2020 Mar 9.
3
Cryo-EM structures of PAC1 receptor reveal ligand binding mechanism.
肝素寡糖通过其结合过程的表征作为血管活性肠肽抑制剂。
Curr Protein Pept Sci. 2024;25(6):480-491. doi: 10.2174/0113892037287189240122110819.
4
PACAP and VIP Neuropeptides' and Receptors' Effects on Appetite, Satiety and Metabolism.垂体腺苷酸环化酶激活肽和血管活性肠肽神经肽及其受体对食欲、饱腹感和新陈代谢的影响。
Biology (Basel). 2023 Jul 17;12(7):1013. doi: 10.3390/biology12071013.
5
Constitutive and conditional deletion reveals distinct phenotypes driven by developmental versus neurotransmitter actions of the neuropeptide PACAP.组成型和条件型缺失揭示了由神经肽 PACAP 的发育和神经递质作用驱动的不同表型。
J Neuroendocrinol. 2023 Nov;35(11):e13286. doi: 10.1111/jne.13286. Epub 2023 Jun 12.
6
GPCRLigNet: rapid screening for GPCR active ligands using machine learning.GPCRLigNet:使用机器学习快速筛选 GPCR 活性配体。
J Comput Aided Mol Des. 2023 Mar;37(3):147-156. doi: 10.1007/s10822-023-00497-2. Epub 2023 Feb 25.
7
Understanding VPAC receptor family peptide binding and selectivity.理解 VPAC 受体家族肽结合和选择性。
Nat Commun. 2022 Nov 16;13(1):7013. doi: 10.1038/s41467-022-34629-3.
8
Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery.基于结构的GPCR药物发现中的基本动力学集成对接
Front Mol Biosci. 2022 Jun 29;9:879212. doi: 10.3389/fmolb.2022.879212. eCollection 2022.
9
Investigation of the Role of Pituitary Adenylate Cyclase-Activating Peptide (PACAP) and Its Type 1 (PAC1) Receptor in Uterine Contractility during Endometritis in Pigs.探讨垂体腺苷酸环化酶激活肽(PACAP)及其 1 型受体(PAC1)在猪子宫内膜炎时子宫收缩中的作用。
Int J Mol Sci. 2022 May 13;23(10):5467. doi: 10.3390/ijms23105467.
10
GPCR Intracellular Loop Regulation of Beta-Arrestin-Mediated Endosomal Signaling Dynamics.G 蛋白偶联受体细胞内环调节β-arrestin 介导的内体信号动力学。
J Mol Neurosci. 2022 Jun;72(6):1358-1373. doi: 10.1007/s12031-022-02016-8. Epub 2022 May 10.
PAC1 受体的冷冻电镜结构揭示了配体结合机制。
Cell Res. 2020 May;30(5):436-445. doi: 10.1038/s41422-020-0280-2. Epub 2020 Feb 11.
4
Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.朝向 B 类 G 蛋白偶联受体肽结合和激活的结构理解。
Mol Cell. 2020 Feb 6;77(3):656-668.e5. doi: 10.1016/j.molcel.2020.01.012. Epub 2020 Jan 30.
5
Targeting the PAC1 Receptor for Neurological and Metabolic Disorders.针对神经和代谢紊乱的 PAC1 受体。
Curr Top Med Chem. 2019;19(16):1399-1417. doi: 10.2174/1568026619666190709092647.
6
Assessment of Conformational State Transitions of Class B GPCRs Using Molecular Dynamics.利用分子动力学评估B类G蛋白偶联受体的构象状态转变
Methods Mol Biol. 2019;1947:3-19. doi: 10.1007/978-1-4939-9121-1_1.
7
PAC1 Receptors: Shapeshifters in Motion.PAC1 受体:运动中的变形者。
J Mol Neurosci. 2019 Jul;68(3):331-339. doi: 10.1007/s12031-018-1132-0. Epub 2018 Aug 3.
8
Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.偏向激动剂结合的人 GLP-1 受体-Gs 复合物的相衬 cryo-EM 结构。
Nature. 2018 Mar 1;555(7694):121-125. doi: 10.1038/nature25773. Epub 2018 Feb 21.
9
Structure of the glucagon receptor in complex with a glucagon analogue.胰高血糖素受体与胰高血糖素类似物复合物的结构。
Nature. 2018 Jan 3;553(7686):106-110. doi: 10.1038/nature25153.
10
Conformational Transitions of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor, a Human Class B GPCR.垂体腺苷酸环化酶激活肽受体的构象转变,一种人类 B 类 GPCR。
Sci Rep. 2017 Jul 14;7(1):5427. doi: 10.1038/s41598-017-05815-x.